According to Prelude Therapeutics's latest financial reports the company's current earnings (TTM) are -โน11.94 B. In 2023 the company made an earning of -โน11.1 B a decrease over its 2022 earnings that were of -โน10.37 B.The earnings displayed on this page is the company's Pretax Income.